医脉通编译整理，未经授权请勿转载。 侵袭性真菌感染（IFIs）是免疫功能低下和儿童危重患者发病和死亡的重要原因。儿童患者与成人不同（尤其是危重患者），念珠菌和曲霉菌是导致儿科患者IFIs 的最常见真菌。儿童 IFIs ...

The pharmacology, bioavailability and pharmacokinetics, clinical efficacy, and adverse effects of caspofungin acetate are reviewed. Caspofungin acetate is an echinocandin with fungicidal activity ...

The "Anti Fungal Drugs - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.In a comprehensive analysis, experts forecast the ...

Neeraj Chauhan, Ph.D., an associate professor in the Center for Discovery and Innovation at Hackensack Meridian Health, ...

One of the greatest threats to hospitalized patients is the acquisition of healthcare-associated infections. The risks of morbidity and mortality increase significantly in affected patients for two ...

This new information opens opportunities to devise more effective uses of antifungal drugs. The results were published July 31 in the journal Nature Communications. "In order to improve the use of ...

One thing is certain: The threat of fungal infections is growing, as fungi either evolve ways to evade drugs that once worked, or pop up in places they haven’t been seen before. “We have limited ...

Many of the fungal pathogens are resistant to treatment with current drugs—of which only four ... Another issue is that antifungal drug development takes a long time and is very expensive.

The global market for histoplasmosis treatment is expected to grow significantly, with sales estimated at USD 4,670.6 million in 2024 and projected to reach USD 8,933.5 million by 2034, reflecting a ...